Recommendations for prevention, diagnosis and management of hypertension and cardiovascular risk factors in sub-Saharan Africa

Journal of Hypertension

Volumn 21, Issue 11, 2003, Pages 1993-2000

  Lemogoum, Daniel ^b   Seedat, Yackoob Kassim ^a   Mabadeje, Abdul Fattah Biola ^b   Mendis, Shanti ^b   Bovet, Pascal ^b   Onwubere, Basden ^b   Blackett, Kathleen Ngu ^b   Lenfant, Claude ^b   Kabangu, Jean René M'Buyamba ^b   Block, Pierre ^b   Belhocine, Mohamed ^b   Degaute, Jean Paul ^b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b NONE

Author keywords

Diagnosis; Management and control of hypertension; Prevention; Recommendations; Sub Saharan Africa

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DIAZEPAM; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; FUROSEMIDE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; METHYLDOPA; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PRAZOSIN; RESERPINE; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

AFRICA; AMBULATORY MONITORING; ANAMNESIS; ANGINA PECTORIS; ARTERIAL PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CLINICAL EXAMINATION; DATA ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET; DISEASE ASSOCIATION; DRUG TOLERABILITY; EVALUATION; EXERCISE; FOLLOW UP; HEALTH PROGRAM; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; LABORATORY TEST; LOW DRUG DOSE; PATIENT EDUCATION; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCREENING; SEX DIFFERENCE; SPHYGMOMANOMETER; STROKE; SYSTOLIC BLOOD PRESSURE;

EID: 10744229022     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200311000-00003     Document Type: Review

References (24)

1. SA Hypertension Society Executive Committee. South African Hypertension Clinical guideline 2002. S Afr Med J 2002; 92:171-172.
2. Mabadeje AF. 1999 WHO-ISH Guidelines for management of hypertension: implementation in Africa - the Nigerian experience. Nigerian Guidelines. Clin Exp Hypertens 1999; 21:671-681.
3. Seedat YK. Hypertension in black South Africans. J Hum Hypertens 1999; 13:97-103.
4. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic: the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-2997.
5. Wright JT, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 2002; 288:2421-2431.
6. WHO/ISH. 2003 World Health Organization/International Society of Hypertension Statement on Management of Hypertension. J Hypertens 2003; 21:1983-1992.
7. WHO. CVD-Risk Management Package for Low and Medium Resource Settings. Geneva: WHO; 2002.
8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2571.
9. ESH/ESC. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
10. Douglas JG, Bakris GL, Epstein M, Ferdinand KC, Ferrario C, Rack JM, et al. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 2003; 163:525-541.
11. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, et al., on behalf of the European Working Group on Blood Pressure Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21:821-848.
12. O'Brien E, Atkins N. A website for blood pressure monitoring devices. Blood Press Monit 2003; 8:177-179.
13. The problem of overweight and obesity. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. WHO Technical Report Series 894. Geneva: WHO; 2000, p. 537.
14. Oparil S, Wang JG, Bakir S, Staessen JA. New Outcome Trials of Antihypertensive Treatment. In: Schachter M, Kaplan N (editors): New frontiers in hypertension. London: Lippincott Williams and Wilkins; 2002, pp. 61-99.
15. Staessen JA, Wang JG and Birkenhager WH. Outcome beyond blood pressure control? Eur Heart J 2003; 24:504-514.
16. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al. Primary prevention of hypertension: Clinical and public health advisory from the National High Blood Pressure Education Program Coordinating Committee. JAMA 2002; 288:1882-1888.
17. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists and other blood pressure lowering drugs: results of prospectively designed overviews of randomized overviews of randomized trials. Blood Pressure Treatment Trialists' Colloboration. Lancet 2000; 356:1955-1964.
18. Seedat YK. Malignant accelerated hypertension In: Mancia G, Chalmers J, Julius S, Saruta T, Weber M, Ferrari A, Wilkinson I (editors): Manual of hypertension. London: Churchill Livingstone Harcourt Publishers Limited; 2002, pp. 623-634.
19. International Society of Hypertension Writing Group. International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. J Hypertens 2003; 21:666-672.
20. Nissinen A, Bothig S, Granroth H, Lopez AD. Hypertension in developing countries. World Health Stat Q 1988; 41:141-154.
21. Edwards R, Unwin N, Mugusi F, Whiting D, Rashid S, Kissima J, Aspray TJ, et al. Hypertension prevalence and care in an urban and rural area of Tanzania. J Hypertens 2000; 18:145-152.
22. Steyn K, Gaziano TA, Bradshaw D, Laubscher R, Fourie J. South African Demographic and Health Coordinating Team. Hypertension in South African adults: results from the Demographic and Health Survey, 1998. J Hypertens 2001; 19:1717-1725.
23. Seedat YK. Hypertension in developing nations in sub-Saharan Africa. J Hum Hypertension 2000; 14:739-747.
24. Cohn JN, Tognoni GA, on behalf of the VALHEFT Trial Investigators. Randomised trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001; 345:1667-1675. 2000